Sometimes that's true
Im obviously not here to endorse peptides (or play TGA/FDA cop)
There are no established dosing guidelines for Cagrilintide (10mg) outside of regulated clinical research settings
Safety depends on the peptide, dose, source quality, delivery method, medical history, and provider supervision
Existing studies on neurodegenerative diseases reveal impairments related to BBB dysfunction, including compromised vascular stability, disrupted CBF, and vascular inflammation
Advances in metabolite processing methods and metabolite identification tools, such as Bio-Transformer, are expected to further expand the number of annotated metabolites, enhancing the comprehensive coverage enabled by of metabolic databases (Djoumbou-Feunang et al., 2019